Indian Prime Minister Narendra Modi today said there are requests to India from Bangladesh, Myanmar, Qatar and Bhutan for holding vaccine clinical trials in their countries.
He also said two Pan-Indian studies on the genome of SARS CoV-2 (Covid-19 virus) in India conducted by the Indian Council of Medical Research and the Department of Biotechnology suggest that the coronavirus is “genetically stable across India and there is no major mutation in the virus.”
Speaking at a high-level meeting in New Delhi to review the coronavirus situation, he said Indian scientists and research teams are collaborating and strengthening their research capacities in Bangladesh, Afghanistan, Bhutan, Maldives, Mauritius, Nepal and Sri Lanka.
“There are further requests from Bangladesh, Myanmar, Qatar and Bhutan for clinical trials in their countries,” an official statement quoted Modi as saying.
Modi suggested a vaccine delivery system be developed on the lines of conduct of elections, involving all levels of governments and citizen groups.❐
